Amancio Nhangave
Overview
Explore the profile of Amancio Nhangave including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ismael N, Hussein C, Magul C, Inguane H, Couto A, Nhangave A, et al.
Pathogens
. 2025 Jan;
14(1).
PMID: 39861009
Real-world data on HIV drug resistance (HIVDR) after transitioning to tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD) are limited. We assessed HIVDR rates and patterns in clients with virological failure (VF) after switching...
2.
Meque I, Herrera N, Nhangave A, Mandlate D, Guilaze R, Tambo A, et al.
South Afr J HIV Med
. 2024 Aug;
25(1):1578.
PMID: 39113779
Background: In 2022, Mozambique introduced Dolutegravir 10mg (pDTG), as part of paediatric antiretroviral therapy for children weighing < 20 kg. Understanding real-world challenges during national rollout can strengthen health systems...
3.
Meque I, Herrera N, Gill M, Guilaze R, Nhangave A, Mussa J, et al.
Trop Med Infect Dis
. 2024 Jul;
9(7).
PMID: 39058183
With the increase in uptake of multi-month antiretroviral therapy dispensing (MMD) for children, little is known about consistency of MMD receipt over time and its association with virological outcomes. This...
4.
Gill M, Herrera N, Guilaze R, Mussa A, Dengo N, Nhangave A, et al.
Pediatr Infect Dis J
. 2023 Jul;
42(10):893-898.
PMID: 37409808
Background: Dolutegravir (DTG) was scaled up globally to optimize treatment for children living with HIV. We evaluated the rollout and virological outcomes after DTG introduction in Mozambique. Methods: Data from...
5.
Songane M, Magaia C, Couto A, Dengo N, Cassamo A, Nhantumbo R, et al.
PLoS One
. 2023 May;
18(5):e0286458.
PMID: 37235565
Background: In Mozambique, 38.7% of women and 60.4% of men ages 15-59 years old living with HIV do not know their HIV status. A pilot home-based HIV counseling and testing...